Cystic Fibrosis-Related Pancreatic Cysts Decrease in Size and Number Upon Treatment With Cystic Fibrosis Transmembrane Conductance Regulator Modulators

被引：1
|
作者：
de Vries, Jonathan M. [1 ]
Green, Deanna [2 ]
Kucera, Jennifer N. [3 ]
Fabbrini, Abigail L. [1 ]
Kidder, Molly [4 ]
Brown, Jerry [1 ]
Wilsey, Michael [1 ]
机构：
[1] Johns Hopkins All Childrens Hosp, Dept Pediat Gastroenterol & Nutr, St Petersburg, FL 33701 USA
[2] Johns Hopkins All Childrens Hosp, Dept Pediat Pulmonol, St Petersburg, FL USA
[3] Johns Hopkins All Childrens Hosp, Dept Radiol, St Petersburg, FL USA
[4] Johns Hopkins All Childrens Hosp, Dept Pediat & Adolescent Med, St Petersburg, FL USA
来源：
PANCREAS | 2020年 / 49卷 / 06期
关键词：
D O I：
10.1097/MPA.0000000000001567
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E50 / E51
页数：2
相关论文
共 50 条
  • [21] Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic FibrosisProgress to Date
    Frédéric Becq
    Drugs, 2010, 70 : 241 - 259
  • [22] Beneficial effect of cystic fibrosis transmembrane conductance regulator modulators on adults with cystic fibrosis liver disease
    Manioudaki, Sofia
    Vasilieva, Larisa
    Mani, Ilianna
    Diamantea, Filia
    Alexopoulos, Theodoros
    Pouriki, Sophia
    Athanassa, Zoe
    Sakagianni, Aikaterini
    Geladari, Eleni
    Elefsiniotis, Ioannis
    Hadziyannis, Emilia
    Alexopoulou, Alexandra
    JOURNAL OF HEPATOLOGY, 2023, 78 : S978 - S979
  • [23] Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage
    Zhang, Shuzhong
    Shrestha, Chandra L.
    Kopp, Benjamin T.
    SCIENTIFIC REPORTS, 2018, 8
  • [24] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Ramsey, Mitchell L.
    Wellner, Michael R.
    Porter, Kyle
    Kirkby, Stephen E.
    Li, Susan S.
    Lara, Luis F.
    Kelly, Sean G.
    Hanje, A. James
    Sobotka, Lindsay A.
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 411 - 419
  • [25] Cystic fibrosis liver disease in the new era of cystic fibrosis transmembrane conductance regulator (CFTR) modulators
    Eldredge, Jessica A.
    Oliver, Mark R.
    Ooi, Chee Y.
    PAEDIATRIC RESPIRATORY REVIEWS, 2024, 50 : 54 - 61
  • [26] Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy
    Blumenfeld, Yair J. J.
    Hintz, Susan R. R.
    Aziz, Natali
    Barth, Richard A. A.
    Spano, Jacquelyn M. M.
    El-Sayed, Yasser Y. Y.
    Milla, Carlos
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (07) : 1015 - 1016
  • [27] The Role of Cystic Fibrosis Transmembrane Conductance Regulator Modulators After Liver Transplantation in Persons With Cystic Fibrosis
    Maradiaga, Richard
    Ramsey, Mitchell
    Kirkby, Stephen
    Sobotka, Lindsay
    ACG CASE REPORTS JOURNAL, 2024, 11 (01)
  • [28] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Mitchell L Ramsey
    Michael R Wellner
    Kyle Porter
    Stephen E Kirkby
    Susan S Li
    Luis F Lara
    Sean G Kelly
    A James Hanje
    Lindsay A Sobotka
    World Journal of Hepatology, 2022, (02) : 411 - 419
  • [29] Cystic Fibrosis Transmembrane Conductance Regulator Modulators Reduce Hospitalizations for Acute Pancreatitis in Patients With Cystic Fibrosis
    Ramsey, M. L.
    Sobotka, L. A.
    Wellner, M. R.
    Porter, K.
    Lara, L. F.
    PANCREAS, 2020, 49 (10) : 1425 - 1426
  • [30] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Parisi, Giuseppe Fabio
    Mollica, Federico
    Giallongo, Alessandro
    Papale, Maria
    Manti, Sara
    Leonardi, Salvatore
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)
12345